Morbidity and mortality of sickle cell disease patients starting intermittent haemodialysis: a comparative cohort study with non- Sickle dialysis patients-Reference-Cited by-同舟云学术

Morbidity and mortality of sickle cell disease patients starting intermittent haemodialysis: a comparative cohort study with non- Sickle dialysis patients

Published:2016-03-17 Issue:1 Volume:174 Page:148-152
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Nielsen Louise¹²,Canouï-Poitrine Florence³⁴,Jais Jean-Philippe⁵⁶,Dahmane Djamal¹,Bartolucci Pablo⁷⁸⁹,Bentaarit Bouteina¹,Gellen-Dautremer Justine⁷,Remy Philippe¹²,Kofman Tomek¹²,Matignon Marie¹²,Suberbielle Caroline¹⁰,Jacquelinet Christian¹¹¹²,Wagner-Ballon Orianne¹³¹⁴,Sahali Dil¹²,Lang Philippe¹²,Damy Thibaud¹⁵¹⁶,Galactéros Frédéric⁷⁸⁹,Grimbert Philippe¹²,Habibi Anoosha⁷⁸⁹,Audard Vincent¹²

Affiliation:

1. AP-HP (Assistance Publique-Hôpitaux de Paris); Groupe Hospitalier Henri Mondor-Albert Chenevier; Service de Néphrologie et Transplantation; Institut Francilien de Recherche en Néphrologie et Transplantation (IFRNT); Centre de Référence Maladie Rare Syndrome Néphrotique Idiopathique; Créteil France

2. Université Paris-Est-Créteil, (UPEC); DHU (Département Hospitalo-Universitaire) VIC (Virus-Immunity-Cancer); IMRB (Institut Mondor de Recherche Biomédicale); Equipe 21; INSERM U 955; Créteil France

3. AP-HP; Groupe Hospitalier Henri Mondor-Albert Chenevier; Service de Santé Publique; Créteil France

4. UPEC; DHU A-TVB (Aging-Thorax-Vessels-Blood); IMRB; EA 4393 CEpiA (Clinical Epidemiology And Ageing Unit); Créteil France

5. Université Paris Descartes; INSERM UMRS 1138 Equipe 22; Paris France

6. AP-HP; Hôpital Necker Enfants Malades; Biostatistics & Ile de France REIN Registry Epidemiologic Units; Paris France

7. AP-HP; Centre de Référence des Syndromes Drépanocytaires Majeurs; Groupe Hospitalier Henri Mondor-Albert Chenevier; Créteil France

8. AP-HP; Service de Médecine Interne; Groupe Hospitalier Henri Mondor-Albert Chenevier; Créteil France

9. UPEC; INSERM 955; Equipe 2 Emergente; Créteil France

10. Laboratoire Régional d'Histocompatibilité; Hôpital Saint-Louis; Paris France

11. Pôle Rein-Simulation; Direction Générale Médicale et Scientifique; Agence de la Biomédecine; Saint Denis France

12. Inserm U1018; Centre de Recherches en Épidémiologie et Santé des Populations; Villejuif France

13. APHP; Département d'Hématologie et d'Immunologie Biologiques; Groupe Hospitalier Henri Mondor-Albert Chenevier; Créteil France

14. UPEC; INSERM U955; Equipe 9; DHU VIC; Créteil France

15. APHP; Département de Cardiologie and Réseau Amylose Mondor; Groupe Hospitalier Henri Mondor-Albert Chenevier; Créteil France

16. UPEC; INSERM U955; Groupe de Recherche Clinique (GRC) Amyloid Research Insitute; DHU A-TVB; Créteil France

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.14040/fullpdf

Reference12 articles.

1. Sickle cell nephropathy at end-stage renal disease in the United States: patient characteristics and survival;Abbott;Clinical Nephrology,2002

2. Thrombosis and sickle cell disease;De Franceschi;Seminars in Thrombosis and Hemostasis,2011

3. Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme;Falk;New England Journal of Medicine,1992

4. Improved survival among sickle cell kidney transplant recipients in the recent era;Huang;Nephrology Dialysis Transplantation,2013

5. Vascular access morbidity and mortality: trends of the last decade;Lok;Clinical Journal of the American Society of Nephrology,2013

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sickle Cell Disease and CKD: An Update;American Journal of Nephrology;2023-10-27

2. Sickle Cell Disease and the Kidney;Hematology/Oncology Clinics of North America;2022-12

3. An Overview of Solid Organ Transplantation in Patients With Sickle Cell Disease;Transplantation;2022-10-10

4. The nephropathy of sickle cell trait and sickle cell disease;Nature Reviews Nephrology;2022-02-21

5. Assessment of soluble receptor for advance glycation end product level in patients suffering from sickle cell anemia related with nephropathy;PROCEEDING OF THE 1ST INTERNATIONAL CONFERENCE ON ADVANCED RESEARCH IN PURE AND APPLIED SCIENCE (ICARPAS2021): Third Annual Conference of Al-Muthanna University/College of Science;2022